StockWatch
·

ACS Technologies Ltd Q2 FY27 Results

ACSTECHQ2 FY27 Results
Filing
Result:Good· Market: Up#Broad based#Base effect#Margin squeeze
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue113.9819.8%136.2%
Total Income114.0119.8%136.0%
Expenditure104.4616.8%135.1%
PBT9.5566.0%146.2%
Net Profit6.5867.8%177.7%
OPM10.12%2.18pp0.71pp
NPM5.77%1.65pp0.86pp
EPS0.7616.9%94.9%
View full financials

Revenue/PAT more than doubled YoY off a small, acquisition-aided base with no one-offs, but the sector's core EBIT/operating margin actually eased YoY (10.12% vs 10.83%) even as net margin expanded, capping this below a top-tier print.

Q2 FY-2027 RESULTS · ACSTECH

ACS Technologies: consolidated PAT up 178% YoY as revenue more than doubles to ₹114 Cr

PAT +177.64% YoY · revenue +136.22% · margins expanding

12 Nov 2026 · 3 min read
Revenue

₹113.98 Cr

+136.22% YoY

PAT (consolidated)

₹6.58 Cr

+177.64% YoY

Net margin

5.77%

+0.9pp YoY

EPS

₹0.76

ACS Technologies' consolidated revenue grew 136% YoY to ₹113.98 Cr (₹48.25 Cr in Q2 FY26) and 19.8% QoQ from ₹95.12 Cr in Q1 FY27, while consolidated PAT rose 178% YoY to ₹6.58 Cr (₹2.37 Cr) and 68% QoQ from ₹3.92 Cr — a broad-based scale-up with no exceptional items on either side, so the growth is read on a raw, unadjusted basis. Net profit margin expanded to 5.77% from 4.91% a year ago and 4.12% last quarter, but operating margin (EBITDA/revenue) eased slightly to 10.13% from 10.83% YoY even as it rebounded sharply from Q1's 7.94%, pointing to a cost mix (employee and other expenses) that hasn't fully kept pace with the revenue ramp even as the bottom line outgrew the topline. Standalone, the parent's own revenue grew faster at 178.7% YoY to ₹82.28 Cr (PAT +167.5% to ₹5.38 Cr) than the consolidated figure, because the two subsidiaries — Iotiq Innovations and Innovistas Innovations — added only about 69% YoY growth on their combined ₹31.70 Cr of revenue, diluting the group's growth rate; readers comparing the standalone release separately should expect the higher number there.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹113.98 Cr+19.8%+136.2%
Expenses₹104.46 Cr+16.8%+135.1%
PAT₹6.58 Cr+67.86%+177.64%
Net margin5.77%+1.6pp+0.9pp
EPS₹0.76+16.9%+94.9%

There is no analyst coverage or consensus estimate available for this sub-₹115 Cr-revenue company, so the print cannot be benchmarked against the Street, and management has issued no formal guidance or prior concall commentary on record against which to grade this quarter — both read as 'unknown' rather than a miss. The quarter coincided with a flurry of capital-structure activity: ₹20.38 Cr was raised via share warrants in H1 FY27 (lifting paid-up equity capital to ₹69.44 Cr from ₹60.74 Cr), a 49.5-lakh-share preferential allotment received BSE listing approval on October 19-23, and credit facilities were enhanced by ₹30 Cr on October 31 — all funding lined up alongside the receivables and inventory build (trade receivables up to ₹103.20 Cr from ₹75.97 Cr, inventories to ₹85.80 Cr from ₹80.43 Cr) that typically accompanies this scale of revenue growth. No management press release accompanied this filing, so there is no company framing to reconcile against the numbers beyond the board outcome letter.

₹
44.1455.2866.4177.5588.6972.408-1009-0109-2410-1911-1111-12Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹72.4, up 7.1% over the past month of trading.

₹ Cr
02.464.917.370.82Q1 FY26rev ₹28 Cr2.37Q2 FY26rev ₹48 Cr3.09Q3 FY26rev ₹67 Cr2.24Q4 FY26rev ₹121 Cr3.92Q1 FY27rev ₹95 Cr6.58Q2 FY27rev ₹114 Cr
Quarterly consolidated PAT, ₹ Crore

For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 2 consecutive quarters.

Beyond the headline

What the summary numbers don't show

Consolidated basic EPS ₹0.76 vs ₹0.39 YoY and ₹0.65 QoQ

  • W1

    Whether OPM recovers back toward the ~10.8% YoY level — it dipped to 7.94% in Q1 FY27 before rebounding to 10.13% this quarter

  • W2

    Subsidiary (Iotiq/Innovistas) combined revenue growth, currently ~69% YoY on ₹31.70 Cr — well behind standalone's 178.7% YoY pace

  • W3

    Deployment of the ₹20.38 Cr share-warrant proceeds and the ₹30 Cr enhanced credit facility (Oct 31, 2026) against the receivables/inventory build

Figures converted from ₹ Lakhs. No exceptional items in either period. Current-quarter consolidated Net Profit/(Loss) row shows NCI as nil while the Total Comprehensive Income row attributes ₹58.82 Lakh to NCI for the same quarter — a presentation inconsistency in the filing; used the total Net Profit/(Loss) row (658.15 Lakh) as consolidated PAT, matching the convention in our prior-period DB context figures.

Informational and educational content only. Not investment advice.